Home > Newsletters > FDAnews Drug Daily Bulletin > ACRO Seeks Clarification of India’s Proposed Trial Compensation Formula
FDAnews Drug Daily Bulletin
Aug. 29, 2012 | Vol. 9 No. 170
ACRO Seeks Clarification of India’s Proposed Trial Compensation Formula
A newly released draft guideline on clinical trial death and injury compensation in India has clinical researchers concerned about how the basis for claims will be decided and payments formulated. In particular, the Association of Clinical Research Organizations (ACRO) wants the Central Drugs Standard Control Organization (CDSCO) to clarify the role “risk factors” will play in setting compensation, spokesman John Lewis told CTA.
Clinical Trials Advisor
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.